The public interest group Consumer Watchdog doesn’t have standing to challenge the U.S. Patent and Trademark Office’s decision to uphold a patent on human embryonic stem cells, according to a ruling Wednesday by the U.S. Court of Appeals for the Federal Circuit.
The decision will affect public interest organizations such as Consumer Watchdog and the Electronic Frontier Foundation, which have challenged patents they oppose on policy grounds. While they can continue to lodge challenges at the Patent Trial and Appeal Board in the PTO, they won’t be able to appeal an adverse decision to the Federal Circuit.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
